These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22462602)

  • 21. Questions remain about the human papillomavirus vaccine.
    Printz C
    Cancer; 2009 Feb; 115(4):699-701. PubMed ID: 19189370
    [No Abstract]   [Full Text] [Related]  

  • 22. Introducing human papillomavirus vaccines - questions remain.
    Paavonen J; Lehtinen M
    Ann Med; 2008; 40(3):162-6. PubMed ID: 18382882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advisory report from the Health Council of the Netherlands to include human papillomavirus vaccination in the national immunisation programme for the prevention of cervical cancer].
    Boeke AJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):981-3. PubMed ID: 18549170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Who should be vaccinated against human papillomavirus?
    Tjalma WA; van Damme P
    Int J Gynecol Cancer; 2006; 16(4):1498-9. PubMed ID: 16884357
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeting teens and adolescents for HPV vaccine could draw fire.
    Washam C
    J Natl Cancer Inst; 2005 Jul; 97(14):1030-1. PubMed ID: 16030298
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of quadrivalent HPV vaccination on HPV related disease in women treated for cervical or vulvar/vaginal disease.
    Kim JJ
    BMJ; 2012 Mar; 344():e1544. PubMed ID: 22454090
    [No Abstract]   [Full Text] [Related]  

  • 27. HPV and cervical cancer in the 2007 report.
    WHO/ICO Information Centre on HPV and Cervical Cancer
    Vaccine; 2007 Nov; 25 Suppl 3():C1-230. PubMed ID: 18068032
    [No Abstract]   [Full Text] [Related]  

  • 28. [BENEFITS AND RISKS AT IMPLEMENTATION OF PROPHILACTIC VACCINES FOR CERVICAL CANCER].
    Zlatkov V; Kostova P
    Akush Ginekol (Sofiia); 2016; 55(3):28-33. PubMed ID: 27514142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV9 Vaccine for the Prevention of Human Papillomavirus-Related Cancers.
    Fontenot HB; Fantasia HC
    Nurs Womens Health; 2015; 19(4):365-70. PubMed ID: 26264802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two HPV vaccines yielding similar success.
    Washam C
    J Natl Cancer Inst; 2005 Jul; 97(14):1030. PubMed ID: 16030297
    [No Abstract]   [Full Text] [Related]  

  • 31. Human papillomaviruses (HPV) vaccines: implementation and communication issues.
    Kane MA
    J Fam Plann Reprod Health Care; 2008 Jan; 34(1):3-4. PubMed ID: 18201395
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduction in subsequent HPV related disease was unrelated to vaccination.
    Fiala C
    BMJ; 2012 May; 344():e3195; author reply e3198. PubMed ID: 22570208
    [No Abstract]   [Full Text] [Related]  

  • 33. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
    Tomson TT; Roden RB; Wu TC
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STD vaccine breakthrough. Cervarix would prevent human papilloma virus which can lead to cervical cancer; FDA approval anticipated.
    Health News; 2005 Oct; 11(10):6-7. PubMed ID: 16250092
    [No Abstract]   [Full Text] [Related]  

  • 35. Human papillomavirus vaccine, teen sex and politics.
    Olatunbosun O
    J Fam Plann Reprod Health Care; 2006 Apr; 32(2):74. PubMed ID: 16824294
    [No Abstract]   [Full Text] [Related]  

  • 36. [Advances in Understanding Carcinogenetic Mechanisms of the Human Papillomavirus and Vaccines Based on Virus-like Particles].
    Zhao Z; Wang L; Ma B
    Bing Du Xue Bao; 2015 Mar; 31(2):180-6. PubMed ID: 26164945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine against papilloma virus: a review of the clinical studies.
    Gabutti G
    J Prev Med Hyg; 2009 Jun; 50(2):79-89. PubMed ID: 20099437
    [No Abstract]   [Full Text] [Related]  

  • 38. IPVS Policy statement on safety of HPV vaccines.
    .
    Papillomavirus Res; 2016 Dec; 2():9-10. PubMed ID: 29074192
    [No Abstract]   [Full Text] [Related]  

  • 39. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
    Han JJ; Tarney CM; Song J
    Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [To prevent HPV-associated neoplasia].
    Gross G
    Dtsch Med Wochenschr; 2014 Aug; 139(31-32):1605. PubMed ID: 25076317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.